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ABSTRACT
As cost-benefit analyses are required to prioritize 
and promote disease control and eradication programs 
within a jurisdiction, national data relating to disease-
related production losses are particularly useful. The 
objectives of the current study were to use Irish bovine 
herpesvirus 1 (BoHV-1) prevalence data in dairy herds, 
obtained by bulk milk sampling on 4 occasions over the 
2009 lactation, to document associations between milk 
production, fertility performance, mortality, and BoHV-
1 herd status. Bulk milk (n = 305) antibody ELISA was 
used to classify farms as positive or negative in terms 
of endemic BoHV-1. Cow-level (milk parameters only) 
and herd-level performance data were sourced from the 
Irish Cattle Breeding Federation. Ordinary linear and 
negative binomial regressions were used to investigate 
associations between milk, fertility, and mortality per-
formance and herd-level BoHV-1 results (both categori-
cal and continuous variables). Only slight effects on the 
rates of carryover cows, nonpregnant cows, and total 
deaths were highlighted with increasing ELISA sam-
ple/positive (%) values (incidence rate ratio = 1.001). 
Multiparous cows in herds BoHV-1 bulk milk antibody 
positive recorded a reduction in milk yield per cow 
per year of 250.9 L in the multivariable linear model. 
Milk fat and protein yields were also affected by herd 
BoHV-1 status, again highlighting sub-optimal milk 
production in BoHV-1 bulk milk-positive herds. The 
current study has highlighted an economical method 
of investigating losses due to endemic infection using 
repeated bulk milk sampling over a single lactation. 
These data can contribute to analyzing the cost-benefit 
of applying BoHV-1 control strategies both on farm 
and at a national level.
Key words: bovine herpesvirus 1, dairy herd, milk, 
fertility, mortality
INTRODUCTION
Approximately 80% of the world’s population live 
in developing countries, and the demand for meat and 
milk products in these countries is growing (Delgado, 
2003; Narrod et al., 2012). In developed countries, con-
sumption of these products is reducing, but the qual-
ity of product demanded is increasing (Narrod et al., 
2011). To meet the demands of expanding markets and 
increased quality of product while remaining competi-
tive, livestock producers will require improvements to 
the efficiency of animal production. Based on World 
Organisation for Animal Health (OIE) estimates that 
20% of livestock production losses are directly related 
to animal disease (Vallat, 2008), epidemiological in-
vestigations outlining the specifics of disease-related 
production losses are necessary.
Planning and monitoring of disease eradication 
or control programs is most effective when based on 
knowledge of the prevalence of disease in a given popu-
lation, the factors associated with occurrence of the 
disease, the methods available to control those factors, 
and finally the costs and benefits involved for a particu-
lar region (Thrushfield, 2005). As cost-benefit analyses 
are also required to both prioritize and promote disease 
control and eradication programs within a jurisdiction 
(Narrod et al., 2012), national data relating to disease-
related production losses are particularly useful (Häsler 
et al., 2012).
Infectious bovine rhinotracheitis (IBR), caused by 
bovine herpesvirus 1 (BoHV-1), is a highly contagious 
viral disease of cattle (Engels and Ackermann, 1996; 
Muylkens et al., 2007; Raaperi et al., 2012a). It has a 
worldwide distribution and significant efforts have been 
made, particularly in European Union countries, to 
control and eradicate BoHV-1 (Ackermann and Engels, 
2006). One of the many ways a disease can be character-
ized is by its economic consequences, and the primary 
motivation for eradication of BoHV-1 from livestock 
populations is its reported impact on the economic suc-
cess of farming enterprises. Clinical signs of infection 
include abortion (Givens and Marley, 2008; Graham, 
2013), suboptimal fertility, respiratory disease, reduced 
milk production, and increased mortality under experi-
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mental conditions (Bowen et al., 1985; Chiang et al., 
1990; Miller et al., 1991) and natural field infection.
More specifically, Hage et al. (1998) described a sig-
nificant decrease in milk production of 9.52 kg over a 
14-d infectious period in BoHV-1 seronegative animals 
that became infected with the virus. Statham et al. 
(2015) recently reported a milk yield loss of 2.6 kg/d 
in BoHV-1 seropositive compared with seronegative 
dairy cows. A Dutch modeling exercise quantified losses 
of 0.92 kg of milk per cow per day during a BoHV-
1 herd outbreak (van Schaik et al., 1999). Raaperi 
et al. (2012a) highlighted that herds with a BoHV-1 
within-herd seroprevalence of between 1 and 49%, have 
a higher risk of abortion (odds ratio = 7.3). Moeller 
et al. (2013) reported that 2% of calves submitted for 
necropsy to the California Animal Health and Food 
Safety Laboratory (Tulare, CA) over a 6-yr period had 
lesions consistent with systemic BoHV-1 infection.
Although suboptimal performance due to infection 
with BoHV-1 has been reported widely, it should be 
noted that many studies have yielded contradictory re-
sults. Reproductive losses, for example, have not been 
found to be associated with exposure to BoHV-1 in beef 
herds (Waldner, 2005; Waldner and Kennedy, 2008) or 
in a dairy herd during a subclinical BoHV-1 infection 
(Hage et al., 1998). These contradictory findings are 
most likely due to the timing of infection, differences in 
the type of cattle herds being investigated (beef versus 
dairy), the jurisdiction where the study was completed, 
and livestock management systems operating in those 
jurisdictions. This stresses the importance of complet-
ing investigations specific to a particular region and 
livestock system.
Ireland is a net exporter of agricultural produce, 
with over 90% of dairy produce exported (Geary et 
al., 2010). Most Irish dairy farmers operate a pasture-
based system, and Irish dairy cows graze pasture for 
approximately 10 mo of the year (Drennan et al., 2005). 
Limited data are available on the impact of BoHV-
1 in such a system, and it is important to examine 
whether the effect of BoHV-1 in Ireland is similar to 
that reported previously in more intensive livestock 
systems. Prevalence estimates of BoHV-1 exposure can 
be established using bulk milk analysis. A recent Irish 
study (Sayers et al., 2015) has outlined a bulk milk 
BoHV-1 seroprevalence in Irish dairy herds of 80%. The 
objectives of the current study were to use these Irish 
prevalence data to document associations between milk 
production, fertility performance, mortality and viral 
status.
MATERIALS AND METHODS
Herd Selection and Classification
Selection of herds for this 2009 study was previously 
described, as was their BoHV-1 status (Sayers et al., 
2015). Briefly, milk recording herds and members of 
HerdPlus (a breeding information tool; Irish Cattle 
Breeding Federation, Bandon, Co. Cork, Ireland) re-
corded in the Irish Cattle Breeding Federation (ICBF) 
database were used as the sample population and con-
tained 3,500 members in 2009. Stratified proportional 
random sampling based on herd size and geographical 
location was used to select farmers for participation in 
the study. Of the 500 farmers invited to participate, 312 
were eventually recruited on a voluntary and nonincen-
tivized basis.
Over the 2009 lactation, 4 bulk milk samples (March 
23, June 8, August 31, and November 2) were submitted 
by each study farm. Commercially available ELISA kits 
were used to test bulk milk samples for the presence 
of anti-BoHV-1 antibodies. Relevant kit performance 
data are outlined in Table 1, including manufacturer-
recommended positive cut-off values used to classify 
herds as bulk milk antibody positive or negative.
Analyses were completed by commercial accredited 
laboratories: IBR lysate by National Milk Laborato-
Table 1. The ELISA kits used to test bulk milk samples for anti-bovine herpesvirus 1 (BoHV-1) antibodies in vaccinated and unvaccinated 
study herds
BoHV-1 herd  
vaccination status  BoHV-1 antigen target
Positive 
cut-off value1
Sensitivity  
(%)
Specificity  
(%)
Within-herd 
prevalence  
detectable (%)
Unvaccinated Ultrapurified IBR lysate2 ≥25 
% S/P
100 99.6 10.0–15.03
Vaccinated IBRgE4 ≤0.8 
S/N ratio
72.0–88.4 100 Not available
1S/P (sample/positive) = [optical density at 450 nm of sample (OD450) – OD450 of negative control]/(mean OD450 of positive control – OD450 of 
negative control) × 100; S/N (sample/negative) ratio = (sample mean – absorbance at 650 nm)/negative control mean.
2Institut Pourquier (Montpellier, France). IBR = infectious bovine rhinotracheitis.
3Wellenberg et al. (1998); Kramps et al. (2004).
4Idexx Laboratories (Westbrook, ME).
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ries Ltd. (Wolverhampton, UK), and IBRgE by Enfer 
Diagnostics Ltd. (Naas, Co. Kildare, Ireland). In addi-
tion, bulk milk data were available for each study herd 
from parallel studies regarding their disease status with 
regard to bovine viral diarrhea virus (BVDV; Sayers 
et al., 2015), Neospora caninum, Salmonella species 
(O’Doherty et al., 2013), Ostertagia ostertagi, Dictyo-
caulus viviparus (Bloemhoff et al., 2015a), and Fasciola 
hepatica (Bloemhoff et al., 2015b).
Data relating to on-farm vaccination and biosecurity 
(bioexclusion and biocontainment) protocols were col-
lected by questionnaire from each participating farmer. 
Based on this self-reported information, herds were 
classified as BoHV-1 vaccinated (V) or unvaccinated 
(UV) and as open (introduced animals frequently or 
occasionally to the herd) or closed (never introduced 
new animals to the herd) herds. Biocontainment pa-
rameters recorded were related to cleaning of calving 
and calf pens, ownership of basic veterinary equipment, 
isolation of sick animals, and use of footbaths. A com-
plete set of test results and vaccination data were not 
available for 7 herds and production data were there-
fore sought for 305 herds for inclusion in the analysis.
Production Data
Production data for each study herd were obtained 
from the ICBF database. Individual milk recording test 
day records of milk, fat, and protein yields were down-
loaded from the ICBF database. Predicted daily yields 
from ASReml-fitted splines (Gilmour et al., 2009) were 
used to estimate milk yields per cow per day on bulk 
milk sample collection dates (longitudinal individual 
cow data for mixed-effects models). Additionally, these 
data were used to calculate individual cow 305-d milk, 
fat, and protein yields from which herd averages were 
calculated [herd-level data for fixed effect linear regres-
sion (OLS) models]. Herd-level geometric mean SCC 
was also calculated from individual ICBF cow records. 
Data were collated separately for primiparous (Pp) 
and multiparous (Mp) cows.
To examine herd fertility performance, relevant data 
from 2009 and 2010 breeding and calving seasons were 
downloaded from the ICBF database. Inclusion of 2 
years of data was necessary because calving data from 
2010 were used as an indicator of the success of the 
2009 breeding season. Parameters available included 
herd 3-wk, 6-wk, and 9-wk calving rates (calculated 
from individual calving records) and herd calving 
spread [number of days between start (date when 5 
consecutive calves were born within a 7-d period) and 
end (last calving event) of calving period]. Similar to 
milk production parameters, calving rates and spread 
were calculated for Pp and Mp animals separately. Herd 
calving interval, percentage calves per cow per year, 
replacement rate, percentage cows not in calf, culling 
rate, and percentage of carryover cows was determined 
for the herd as a whole, regardless of parity. Submission 
rates, conception rates, and length of breeding season 
were not available for almost half of study herds and 
these variables were, therefore, not included in the 
analysis.
Neonatal (0–28 d old at death), youngstock (29 d–12 
mo at death), and adult (>12 mo at death) mortal-
ity was examined and the number of cases of each 
calculated. Additionally, the number of deaths among 
youngstock (dead aged >28 ≤ 180 d; dead aged >180 ≤ 
270 d; dead aged >270 ≤ 365 d) and adult (dead aged 
>1 < 2 yr; dead aged >2 yr) sub-categories was also 
calculated. Data relating to the abortion rate on farms 
were not available.
The number of lactating animals (herd size), the par-
ity of lactating animals, herd economic breeding index 
(EBI, €; a single figure profit index that comprises 7 
sub-indices related to profitable milk production in Ire-
land; Veerkamp et al., 2002; Berry et al., 2007), median 
calving date, and proportion of Holstein-Friesian cows 
in each herd in 2009 was also downloaded from the 
ICBF for inclusion in regression models
Descriptive Analysis
Summary statistics were generated in Stata version 
12 (StataCorp, College Station, TX). Means, standard 
errors, and ranges were calculated for all normally 
distributed parameters. Graphical representations of 
production parameters across bulk milk seropositive 
and seronegative herds were plotted in Excel (Microsoft 
Office 2010, Microsoft Corp., Redmond, WA).
Statistical Analysis
All statistical analyses were performed using Stata 
version 12 (StataCorp). Continuous data were visually 
checked for normality using ladders of power histograms 
to choose the most appropriate models for analysis. 
The mean and variance of nonnormally distributed 
dependent variables were calculated. Where the vari-
ance exceeded the mean, negative binomial (NBREG) 
models were applied. Ordinary fixed-effect linear re-
gression was used for normally distributed parameters 
at the herd level and multi-level mixed effects models 
used at the level of individual cow.
Potential confounding variables were selected a priori 
from parallel studies and questionnaire data supplied 
by study farmers. These included bulk milk antibody 
status for BVDV, N. caninum, Salmonella, O. ostertagi, 
D. viviparous, and F. hepatica, and bioexclusion and 
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biocontainment variables, which were used as surrogate 
confounders for general farm management. Chi-squared 
analysis was used to examine associations between 
BoHV-1 bulk milk antibody status and that of other 
diseases. Subsequently, the association between each 
dependent variable (herd performance variables), each 
independent variable (categorical or continuous BoHV-
1 results), and potential disease-related confounders 
was examined using OLS or NBREG, as appropriate. 
If a potential disease-related confounder recorded a 
significant association (P-value of ≤0.15 for this pur-
pose) with both dependent and independent variables, 
it was included in the final regression model. Finally, 
surrogate confounders were included in all final models.
Both univariable and multivariable analyses were 
completed on fertility- and mortality-related param-
eters. Due to the considerable effect that independent 
variables (e.g., calving date, proportion of the herd that 
was Holstein-Friesian) would have on milk-related pa-
rameters, a multivariable analysis alone was completed. 
Two data sets were constructed, one (data set 1) that 
included all herds regardless of vaccination status, 
and a second (data set 2) where only UV herds were 
included. Data set 1 was used in models where categori-
cal bulk milk serostatus (positive vs. negative) was the 
independent variable examined. Data set 2 was used 
to examine the association between ultrapurified IBR 
lysate ELISA readings and production parameters.
Covariates included in all multivariable OLS and 
NBREG models included herd size, proportion of Hol-
stein-Friesian cows in the herd, median calving date, 
and herd EBI value in 2009 (EBI-2009). Average herd 
parity was only included in models where whole-herd 
analyses were conducted and was excluded as a covari-
ate from Pp-specific analyses. Average cow parity (Mp 
cows only) was included in Mp analyses. Second- and 
third-level interactions between independent variables 
were investigated in all models and retained if the in-
teraction term recorded a P-value ≤ 0.05.
Variables were considered significant at P < 0.05 
with tendencies reported at P ≥ 0.05 ≤ 0.15.
RESULTS AND DISCUSSION
A complete set of BoHV-1 prevalence and vacci-
nation data were available for 305 herds, 12% (n = 
36) of which were vaccinated, and 80% (n = 244) of 
which recorded bulk milk positive results (Sayers et 
al., 2015). Chi-squared analysis of BoHV-1 status and 
additional disease status is included in Supplementary 
Table S1 (https://doi.org/10.3168/jds.2016-11113) and 
highlights that associations existed between BoHV-1 
status and F. hepatica (P = 0.035) and N. caninum (P 
= 0.106) bulk milk antibody status, although results 
were not consistent when BoHV-1 vaccination status 
was accounted for. The likelihood of operating an open 
or closed herd did not differ across herds of differing 
BoHV-1 status (P = 0.386). In general, biocontain-
ment measures also did not vary across BoHV-1 bulk 
milk status (Supplementary Table S2; https://doi.
org/10.3168/jds.2016-11113), with the exception of 
owning basic veterinary equipment (P = 0.019).
Mean BoHV-1 ELISA sample/positive (S/P%) 
values for UV herds in March, June, August and No-
vember were 144.76 (SD 83.51; range 0.16 to 408.76), 
169.23 (SD 118.18; range 0 to 347.10), 160.35 (SD 
111.21; range 0 to 306.73), and 198.79 (SD 145.11; 
range 0 to 450.62), respectively. Herd bulk milk se-
rostatus has been previously shown not to significantly 
change over a lactation (Sayers et al., 2015). A single 
V herd recorded a negative result, the remaining 35 
V herds yielding mean sample/negative (S/N) values 
of 0.34, 0.26, 0.36, and 0.35 in March, June, August, 
and November, respectively. A complete set of data for 
287 herds (231 BoHV-1 bulk milk seropositive vs. 56 
BoHV-1 bulk milk seronegative) was available for milk-
related dependent variables, data for 17 UV and 1 V 
herd being unavailable. In the case of mortality and 
fertility parameters, 274 herds (217 BoHV-1 bulk milk 
seropositive vs. 57 BoHV-1 bulk milk seronegative) re-
corded a complete set of data (data set 1). Data were 
unavailable for 27 and 4 UV and V herds, respectively. 
On exclusion of V herds (data set 2), 197 positive and 
55 negative were available for milk analysis, with 56 
negative and 186 positive herds available for mortality 
analysis.
Mean study herd size in 2009 was 99 cows (SD 86; 
range 28 to 445) and the mean proportion of Holstein-
Friesian cows across herds was 0.87 (SD 0.11; range 
0.27 to 1.00). Herd EBI in 2009 ranged from −€16 to 
€120, the mean EBI being just over €75. Average herd 
parity in 2009 was 3.99 (SD 0.45; range 2.00 to 5.31). A 
summary of herd, Mp, and Pp milk performance across 
vaccination status is shown in Table 2, with predicted 
individual cow daily milk yields for approximately 
18,000 animals at each bulk milk sampling time point 
outlined in Table 3. Because of the predominance of 
spring-calving systems in Ireland (Dillon et al., 2008), 
an expected decrease in predicted milk, protein, and fat 
yields on bulk milk sampling dates was observed as the 
year progressed (Figure 1). The mean milk and milk 
solids yields across BoHV-1 bulk milk antibody positive 
and negative herds are outlined in Figure 2.
The mean number of calves born per study herd was 
101 (range 32 to 405). The 2010 Mp mean 3-, 6-, and 
9-wk calving rates were 38.79, 61.29, and 76.99%, re-
spectively, and give an indication of the success of the 
breeding season in 2009. Superior fertility performance 
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was observed in Pp animals, recording mean 3-, 6-, and 
9-wk calving rates of 50.19, 76.33, and 89.63%, respec-
tively. Cow calving spread in 2010 was 111 and 80 d for 
Mp and Pp animals, respectively. The mean proportion 
of cows not calved across study herds was almost 9%. 
Of the 274 herds with recorded mortality data, the 
mean number of deaths per farm was approximately 
13. The mean mortality rate among neonatal calves (0 
to 28 d of age) and youngstock (28 to 365 d) as a per-
centage of calves born was 5.19 and 3.39%, respectively. 
The mean mortality rate among adult stock (>1 yr old) 
was 3.25%.
Univariable and Multivariable OLS  
and NBREG Models
Classification of performance-related dependent vari-
ables into normal and nonnormally distributed catego-
ries is included Supplementary Table S3 (https://doi.
org/10.3168/jds.2016-11113), as is the regression model 
applied for each variable. The variance of all nonnor-
mally distributed variables was greater than the mean, 
and NBREG models were therefore applied in all cases 
with the exception of SCC, which was log-transformed 
and analyzed using OLS regression. Examination of in-
teraction terms between independent variables did not 
highlight any significant interaction terms for inclusion 
in final models.
The results of univariable NBREG analyses for fertil-
ity and mortality parameters are outlined in Table 4. 
Calving rates for Mp cows in 2010 were all significantly 
lower in BoHV-1 positive herds than in negative herds 
(decreasing by a factor of approximately 0.94), although 
this effect was not maintained in multivariable models. 
Of more significance was the increased proportion, by 
a factor of almost 1.4, of carryover cows in 2009 in the 
categorical multivariable model (Table 5). The propor-
tion of cows not calved in 2010 was also increased by 
a factor of 1.001 for every unit increase in BoHV-1 
ELISA S/P% value in the multivariable BoHV-1 con-
Table 2. Study herd mean (SD) [range] annual milk and milk solids yield per cow across parity (multiparous, Mp; primiparous, Pp) and 
vaccination status
Group
305-d yield per cow
SCC 
(×103 cells/mL)Milk (L) Protein (kg) Fat (kg)
All herds regardless of vaccination status (n = 287)
 Herd 5,683.9 (848.7) 209.4 (29.3) 241.4 (32.4) 212.3 (96.9)
[2,862.5, 8,983.2] [115.8, 315.4] [160.5, 376.4] [55.5, 766.2]
 Mp 6,044.4 (886.6) 220.2 (30.1) 252.3 (33.9) 233.9 (114.5)
[2,933.4, 9,786.6] [117.5, 337.8] [163.4, 394.5] [59.2, 895.9]
 Pp 4,633.1 (831.2) 177.6 (28.9) 210.1 (31.8) 141.8 (76.9)
[2,545.9, 8,093.9] [107.8, 292.8] [145.1, 340.92] [39.4, 715.5]
Unvaccinated herds (n = 252)
 Herd 5,660.7 (794.5) 208.7 (27.9) 240.9 (31.3) 210.8 (97.4)
[2,862.5, 8,007.2] [115.8, 290.7] [160.5, 343.1] [55.5, 766.2]
 Mp 6,012.5 (818.3) 219.3 (28.4) 251.6 (32.5) 230.6 (113.9)
[2,933.4, 8,404.9] [117.5, 301.5] [163.4, 377.6] [59.2, 895.9]
 Pp 4,612.5 (777.8) 177.0 (27.2) 209.7 (30.6) 143.1 (80.2)
[2,545.9, 7,294.8] [107.8, 263.9] [145.1, 263.9] [39.4, 715.5]
Vaccinated herds (n = 35)
 Herd 5,851.3 (1,168.5) 214.5 (38.2) 245.1 (40.0) 223.3 (94.0)
[3,570.8, 8,983.2] [139.6, 315.4] [177.7, 376.4] [85.2, 471.7]
 Mp 6,274.3 (1,267.9) 227.2 (40.2) 257.7 (42.9) 257.8 (117.7)
[3,872.7, 9,786.6] [149.4, 337.8] [188.4, 394.5] [92.3, 541.4]
 Pp 4,789.1 (1,145.6) 182.0 (38.9) 212.8 (39.6) 132.7 (46.8)
[2,882.8, 8,093.9] [117.2, 292.8] [153.2, 340.9] [68.2, 288.9]
Table 3. Predicted mean daily milk, protein, and fat yields per cow per day based on individual milk recording data
Sampling 
time point No. of samples
Mean (SD)
Milk yield 
(L/d)
Protein yield 
(kg/d)
Fat yield 
(kg/d) DIM Parity
March 17,771 26.8 (5.0) 0.9 (0.2) 1.0 (0.2) 55.0 (10.3) 3.9 (1.9)
June 18,022 20.9 (4.4) 0.7 (0.2) 0.8 (0.2) 133.0 (10.3) 3.9 (2.0)
August 18,020 15.7 (3.7) 0.6 (0.1) 0.7 (0.1) 216.0 (10.3) 3.9 (2.0)
November 18,019 12.2 (3.1) 0.5 (0.1) 0.6 (0.1) 279.0 (10.3) 3.9 (2.0)
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tinuous variable model. Median calving date and herd 
EBI in 2009 were significant in these models with an 
increase in median calving date associated with inferior 
fertility (incidence rate ratio; IRR ≅ 1.01) and an in-
crease in EBI associated with superior fertility (IRR ≅ 
0.98). Analysis of mortality counts across different age 
groups (calves, youngstock, adults) yielded relatively 
little in terms of an association with BoHV-1 bulk milk 
antibody status. Whole-herd mortality counts, how-
ever, were increased by a factor of 1.001 for every unit 
increase in BoHV-1 ELISA S/P% value (P = 0.023) 
(Table 5).
A 250-L reduction in milk yield per Mp cow per year 
was identified in BoHV-1 positive herds compared with 
BoHV-1 negative herds (P = 0.042; Tables 6 and 7). 
Analysis of continuous data highlighted a comparable 
association in Mp cows in herds with increasing bulk 
milk antibody titers (Table 6). Milk fat and milk pro-
tein yield was reduced by almost 11 kg/cow per year 
(P = 0.033), and 8 kg/cow per year (P = 0.062), re-
spectively. An effect on milk yield was also recorded in 
herds positive for F. hepatica and N. caninum, recording 
a decrease of just over 171 L per Mp cow per year and 
an increase of almost 100 L per Mp cow per year, re-
spectively. No effect on Mp SCC was detected although 
a 12.9% increase in SCC was recorded in Pp cows in 
positive herds (P = 0.055) compared with bulk milk 
negative herds.
Estimates for all variables included in Mp milk and 
milk solids yield models are included in Table 7. An 
increasing proportion of Holstein-Friesian cows led to 
a significantly increased milk and milk solids yield (P 
< 0.001), and an increase in mean EBI of €1 led to 
a milk yield loss of almost 8 L per cow per year (P 
= 0.004). Reductions in milk fat and milk protein, 
however, were not associated with EBI. Interestingly, a 
tendency was highlighted for improved milk production 
parameters in closed compared with open herds (Table 
6). Although significant associations were not identi-
fied for additional explanatory variables in milk-related 
models, R2 values increased on their inclusion, and they 
were therefore retained in final models.
Dairy farmers and their service providers benefit 
from access to data that allow identification and pri-
oritization of areas within their production system 
that require improvement (Enevoldsen et al., 1996). 
Examining the associations between herd disease status 
and performance parameters such as milk production, 
fertility, and mortality, therefore, is of value. In the 
present study, I aimed to highlight associations between 
BoHV-1 herd exposure and herd performance in a 
geographically representative group (O’Doherty et al., 
2013) of Irish dairy herds. Herd exposure to BoHV-1, 
as evidenced by a positive bulk milk ELISA reading, 
was found to be associated with suboptimal milk pro-
duction in particular, highlighting a potential economic 
opportunity for the implementation of effective BoHV-
1 control.
Completion of disease cost-benefit analysis requires a 
measure of disease prevalence within the population of 
interest, whether that is at a herd, regional, or national 
level. National data are particularly useful in achiev-
ing farmer “buy-in” to national control or eradication 
programs, but national prevalence studies are often 
prohibitively expensive (Thrushfield, 2005). Bulk milk 
testing overcomes this issue somewhat, and reliable 
Figure 1. Scatterplot of predicted (a) milk, (b) protein, and (c) 
fat yields per cow versus number of days in milk at each bulk milk 
sampling time point (March, June, August, November).
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Figure 2. Differences in mean milk, fat, and protein yields, and SCC between bovine herpesvirus 1 (BoHV-1) bulk milk-positive and bulk 
milk-negative herds. Data are presented for herd, multiparous (Mp), and primiparous (Pp) cows. Error bars represent SEM of each parameter 
examined.
Table 4. Univariable negative binomial regression analysis of herd mortality and fertility-related parameters across bovine herpesvirus 1 (BoHV-
1) herd status
Production parameter (BoHV-1 status)
All study herds
 
Unvaccinated herds only
IRR1 P-value2 IRR P-value
BoHV-1 categorical variable BoHV-1 continuous variable
Cows not calved (%) 20103 
 (positive vs. negative)
1.310 0.098 1.002 0.002
Carryover cows (%) 2009 
 (positive vs. negative)
1.419 0.015 1.002 0.001
Multiparous 3-wk calving rate (%) 2010 
 (positive vs. negative)
0.934 0.150 0.996 0.049
Multiparous 6-wk calving rate (%) 2010 
 (positive vs. negative)
0.937 0.072 0.999 0.061
Multiparous 9-wk calving rate (%) 2010 
 (positive vs. negative)
0.949 0.043 0.999 0.087
Total calves born per herd (no.) 2010 
 (positive vs. negative)
1.360 <0.001 1.001 <0.001
Total deaths per herd (no.) 2009 
 (positive vs. negative)
1.611 0.001 1.003 <0.001
1IRR = incidence rate ratio.
2Parameters with P-values ≤ 0.15 are reported.
3The 2010 parameters are used as an indication of the success of the 2009 breeding season.
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antibody detection bulk milk test procedures have been 
developed for both BoHV-1 vaccinated and unvacci-
nated herds (Nylin et al., 1999; Kramps et al., 2004). 
Furthermore, there has been a legal requirement for all 
BoHV-1 vaccines administered in Ireland to be marker 
or DIVA (Differentiating Infected from Vaccinated Ani-
mals) vaccines to allow differentiation between infected 
and vaccinated individuals (van Oirschot, 1999) since 
December 31, 2004, which further facilitates the use of 
bulk milk testing in Ireland.
The disadvantage of bulk milk analysis, however, is 
that data relate to the lactating herd only, the disease 
status of which may differ from that of younger livestock 
in the herd. This is particularly true of BoHV-1, where 
youngstock often remain seronegative (after maternally 
derived antibodies have dissipated) until over 2 yr of 
age (Van Wuijckhuise et al., 1998; Solis-Calderon et al., 
2003). It is perhaps not surprising, therefore, that mor-
tality rates of different age groups in study herds did 
not differ between BoHV-1 bulk milk antibody positive 
and negative herds. Although it is very possible that 
endemic BoHV-1 does not affect mortality rates in in-
fected herds, it is also likely that my study design is not 
optimal for identifying such a trend.
Table 5. Multivariable negative binomial regression analysis of significant herd fertility and mortality performance parameters across bovine 
herpesvirus 1 (BoHV-1) herd status and ELISA readings
Production parameter 
and variables compared  
Additional significant variables 
in each model IRR1 95% CI P-value2
Herd status as categorical variable    
 Carryover cows (%) 2009 
  (positive vs. negative)
 1.345 1.016, 1.779 0.038
 Median calving date 1.011 1.004, 1.019 0.004
 EBI-20093 0.979 0.973, 0.986 <0.001
BoHV-1 ELISA as continuous variable    
 Carryover cows (%) 2009  1.001 1.001, 1.003 0.005
 Median calving date 1.012 1.004, 1.021 0.002
 EBI-2009 0.980 0.974, 0.987 <0.001
     
 Cows not calved (%) 20104  1.001 1.000, 1.003 0.047
 Median calving date 1.019 1.009, 1.029 <0.001
 EBI-2009 0.993 0.985, 1.001 0.074
 Total deaths per herd (no.) 2009  1.001 1.000, 1.002 0.023
 Herd size 1.008 1.006, 1.011 <0.001
 Isolating sick animals 1.468 1.051, 2.049 0.024
1IRR = incidence rate ratio.
2Only parameters with P-values ≤ 0.15 are reported.
3Herd economic breeding index in 2009. 
4The 2010 parameters are used as an indication of the success of the 2009 breeding season.
Table 6. Multivariable linear regression analysis of herd, multiparous (Mp) and primiparous (Pp) animal performance parameters across bovine 
herpesvirus 1 (BoHV-1) herd status and ELISA readings
Production parameter 
and variables compared Coefficient 95% CI P-value  Coefficient 95% CI P-value1
BoHV-1 categorical variable BoHV-1 continuous variable
Herd milk yield (L/cow per year) 
 (positive vs. negative)
−200.87 −433.17, 31.42 0.090  −0.62 −1.55, 0.29 0.183
Herd fat yield (kg/cow per year) 
 (positive vs. negative)
−9.02 −18.55, 0.51 0.063  −0.05 −0.08, −0.01 0.024
Herd protein yield (kg/cow per year) 
 (positive vs. negative)
−6.62 −14.98, 1.73 0.120  −0.02 −0.06, 0.01 0.163
Mp milk yield (L/cow per year) 
 (positive vs. negative)
−250.99 −492.42, −9.56 0.042  −0.89 −1.69, −0.10 0.03
Mp fat yield (kg/cow per year) 
 (positive vs. negative)
−10.82 −20.78, −0.87 0.033  −0.04 −0.07, −0.01 0.01
Mp protein yield (kg/cow per year) 
 (positive vs. negative)
−8.12 −16.65, 0.43 0.062  −0.03 −0.06, −0.01 0.03
Pp SCC (% increase in cells/mL) 
 (positive vs. negative)
12.87 −0.01, 0.26 0.055  0.06 0.02, 0.1 <0.01
1Parameters with P-values <0.20 are reported.
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An additional disadvantage of using a bulk milk 
sample is the lack of discriminatory power at the level 
of the individual cow. This does highlight a weakness 
of my regression analysis, in that bulk milk seropositive 
herds will contain both seropositive and seronegative 
individuals. Bulk milk samples for many diseases usu-
ally test to a specified within-herd prevalence; that 
is, a minimum number of seropositive cows will have 
to contribute to the sample for a positive result to 
be recorded (Sekiya et al., 2013), which can lead to 
misclassification of herds. Nekouei et al. (2015) have 
shown that the possibility of herd misclassification 
using bulk milks can be reduced by testing multiple 
samples over a lactation. As my herd classification was 
based on the use of 4 bulk milk samples from each 
herd, the possibility of herd misclassification should 
be reduced considerably. To overcome any issue in this 
regard, however, herd-level analyses were conducted on 
both categorical and continuous bulk milk ELISA data. 
In general, comparable results were obtained across 
multivariable categorical and continuous models and 
use of actual ELISA results avoids the requirement for 
herd classification as positive or negative based on a 
manufacturer recommended positive cut-off value. The 
use of a continuous independent variable may prove a 
more useful approach, therefore, should the potential 
for herd misclassification exist.
Bulk milk testing is an economical and commonly 
used method of determining herd disease status. Many 
farmers now routinely test bulk milk samples for vari-
ous infectious diseases (Sekiya et al., 2013). Use of bulk 
milk data allowed completion of a national study of 
over 250 herds representing a cow population of ap-
proximately 25,000 cows. These data can now be used 
to allow determination of the cost-benefit of applying 
control strategies, an essential step in examining the 
likely financial return from application of national dis-
ease eradication programs (Stott et al., 2012).
Data from herds endemically infected with a disease 
are more useful in convincing farmers to undertake 
control measures, because such data are often more 
reflective of their herd’s disease status (Stott et al., 
2010). Much of the BoHV-1 performance data pre-
sented in the literature relate to disease outbreaks, 
which are often assumed to inflict greater losses on 
a herd. Although this may be the case in the short 
term, continuous losses from endemic infections can be 
substantial in the longer term. Gunn et al. (2004) have 
demonstrated how BVDV-antibody positive herds can 
record substantial ongoing losses due to the presence of 
susceptible animals in a seropositive herd. It is likely 
that BoHV-1 could result in similar ongoing losses due 
to the dynamics of BoHV-1 spread within a herd and 
intermittent reactivation of latent infections in unvac-
cinated carrier animals (Muylkens et al., 2007). Indeed, 
Statham et al. (2015) documented such losses over a 
2-yr longitudinal study in the United Kingdom at the 
individual cow level in a single herd. The subclinical 
milk losses recorded in our study herds were lower than 
that recorded by Statham et al. (2015). This is most 
likely due to the lower milk yields of Irish dairy cows 
(Dillon et al., 2008), leading to losses in milk produc-
tion being proportionally smaller. Additionally, the UK 
study was conducted on a single herd, at the individual 
cow level, which could also account for the differences 
recorded.
As well as an overall herd analysis, investigations of 
Pp and Mp cows were completed to reflect the usual age 
profile of BoHV-1 in herds, a higher proportion of older 
animals within herds being seropositive (Jacevičius 
et al., 2010; Raaperi et al., 2012b). This was a useful 
exercise because it highlighted the fact the Pp cows 
would not appear to be affected by BoHV-1 to the same 
degree as Mp cows. This is potentially due to BoHV-1 
seroconversion in Pp cows occurring only at some point 
during their first lactation. This may account for the 
significant association between BoHV-1 herd status and 
SCC recorded in this sub-population, an association be-
tween BoHV-1 status and SCC having been previously 
reported (Rola et al., 2015). The typically lower milk 
yield of Pp cows (Dematawewa and Berger, 1998) may 
also have affected the ability to detect significant as-
sociations between BoHV-1 herd status and reductions 
in milk yield and solids.
Irish dairy farmers are paid for their produce based 
on milk solids rather than overall milk yield. The pre-
dominance of manufacturing milk (used to produce 
milk powder, butter, and additional milk derived 
products) produced in Ireland (Dillon et al., 2008) re-
quires such a focus. The EBI in Ireland has, therefore, 
been used to reduce the focus on breeding cows for 
milk volume but instead concentrating on maintaining 
levels of milk solids. This is reflected in the multivari-
able results reported in the current study; herd EBI in 
2009 was significantly associated (P = 0.004) with a 
reduction in milk yield, whereas no significant effect on 
milk solids was recorded, which supports the validity 
of the regression model used. Rola et al. (2015) have 
reported an association between milk fat yield and 
BoHV-1 status, and I suggest, based on the current 
results, that an effect on protein yields also occurs. It 
is important to investigate milk composition as well 
as milk yield in studies such as this, particularly in 
regions that focus on manufacture of milk-derived 
products for export. This will allow the full impact of 
endemic BoHV-1 infection in a herd to be quantified 
regardless of milk payment arrangements in particular 
regions and countries.
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A successful dairying operation will aim to achieve 
1 calf per cow every 365 d. Meeting this target is par-
ticularly important in pasture-based systems, such as 
in Ireland, because lactation must coincide with the 
grass growing season (i.e., March to October in the 
Northern Hemisphere). This necessitates a compact 
spring-calving season because cows calving later in 
springtime have shorter lactations thereby reducing 
farm profitability. Calving spread and calving rates 
therefore need to be optimal in pasture-based systems 
(Dillon et al., 1995; McCarthy et al., 2007). Infection 
with BoHV-1 can result in in early embryonic death 
and abortion (Anderson, 2007; Raaperi et al., 2012a), 
both of which have the potential to increase overall 
calving spread and decrease herd calving rates. Abor-
tion can also lead to an increase in carryover cows, 
again adding to the inefficiency of a dairy production 
system (Patton, 2012). Various international studies 
have failed to document associations between BoHV-1 
infection and poor reproductive performance (Hage et 
al., 1998; Pritchard et al., 2003; Waldner and Kennedy, 
2008). The current study would appear to support this, 
although the percentage of carryover cows in 2009 may 
indicate an increased rate of embryonic loss or abortion 
in BoHV-1 bulk milk positive herds.
Raaperi et al. (2012a) showed that infection with 
BoHV-1 is a risk factor for a high incidence of abortions 
and a high insemination index in breeding animals and, 
although not maintained in multivariable models, sig-
nificant associations between Mp fertility parameters 
and BoHV-1 herd status were identified in univariable 
models in the current study. It is interesting to note that 
univariable associations were stronger when the entire 
study population was used for analysis, rather than the 
smaller UV study population. It may be that detection 
of reduced fertility performance in BoHV-1 bulk milk 
positive herds using the current study design may have 
required a larger sample size, although an expected de-
crease (IRR = 0.98) and increase (IRR = 1.01) in the 
rate of carryover cows was highlighted for higher herd 
EBI and later median calving dates, respectively. The 
differences in outcomes across all previously published 
studies and this current study may reflect variances 
in study design (Raaperi et al., 2012a). Larger scale 
studies may be better placed to determine the fertility-
related consequences, if any, due to endemic BoHV-1.
Bovine herpesvirus 1 is a major contributor to bovine 
respiratory disease complex, in conjunction with BVDV, 
parainfluenza 3, and bovine respiratory syncytial virus. 
Bovine respiratory disease complex is a leading cause of 
morbidity and mortality, especially in feedlot systems 
(Van Drunen Little-van den Hurk, 2006). Bovine her-
pesvirus 1 can predispose cattle to secondary bacterial 
pneumonia (Narita et al., 2000; Leite et al., 2002; Nandi 
et al., 2009) and it was expected that mortality rates 
recorded in BoHV-1 positive herds would be increased. 
In general, this was not found to be the case, although 
the total number of deaths in study herds increased 
marginally. Given the high seroprevalence of BoHV-1, 
calves will receive protection via passive transfer from 
the dam, which will reduce the risk of a morbid episode 
(Mechor et al., 1987). As pooling colostrum is common 
in Ireland (Kennedy et al., 2014), it is unlikely that 
calves born even in moderately seropositive herds will 
be completely naïve in the early stages of life, which 
may assist in reducing calf mortality rates.
Identifying and correcting for confounding variables 
in observational studies always presents difficulties 
(Kamangar, 2012). It requires collection of data on 
potential confounders, and in cases where this is not 
possible, collection of data on surrogate confounders. 
The herds used for this analysis were part of a large 
bulk milk prevalence study conducted in Ireland in 
2009. Data relating to several other infectious diseases, 
as well as herd management and biosecurity protocols 
were, therefore, available for analysis. These data al-
lowed investigation of potential disease confounders, 
and use of bioexclusion and biocontainment measures 
employed on each farm as surrogate confounders to rep-
resent farm management. Model fit improved on inclu-
sion of disease- and biosecurity-related variables and, to 
a large degree, estimates across potential confounders 
and covariates yielded logical outcomes. Higher herd 
EBI was significantly associated with improved milk 
solids yield, reduced milk yield, and a decreased rate 
of carryover cows. Later median calving dates were as-
sociated with an increased rate of carryover cows. An 
increased proportion of Holstein-Friesian cows was as-
sociated with higher milk yields, and closed herds also 
tended toward recording improved milk and milk solids 
yields. It may have been expected that median calving 
date would affect milk output. Given the spring-calving 
nature of Irish herds, however, it was not surprising that 
it had little effect. The logical nature of these findings 
supports the statistical methods applied in the current 
analysis and strengthens the findings presented.
The farmer population chosen for this study was the 
population of milk recording herds in Ireland recorded 
in the ICBF database. Not only did this provide access 
to the performance of each herd in terms of milk pro-
duction, but these herds also record fertility and mor-
tality data. With 3,500 herds recorded on the database 
in 2009, this sub-population represented 20% of the 
Irish national dairy herd. The use of stratified random 
selection based on geographical location and herd size 
assisted in selecting nationally representative groups 
of farmers. Although the final population of farmers 
recruited to the study were geographically representa-
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tive of the national dairy population, the mean herd 
size of the group was larger than the national average 
of 55 cows, which may have introduced a degree of bias 
(Teagasc, 2016). As dairy herd size in Ireland has been 
increasing steadily since 2009 (the national average 
herd size in 2015 was 76 cows; CSO, 2016)), the data 
generated in this study may be more representative of 
Irish dairy farms currently.
This study has examined the direct on-farm losses 
associated with the presence of BoHV-1 seropositive 
cows in a dairy herd. What has not been addressed nor 
quantified by any study, to the best of my knowledge, 
are the losses due to trade restrictions for exporting 
nations and genetic losses due to the unsuitability of 
BoHV-1 seropositive bulls for artificial insemination 
breeding programs in many jurisdictions. Such studies 
should be prioritized to provide further cost estimates 
in support of BoHV-1 control programs.
CONCLUSIONS
The current study highlights an economical method 
of investigating losses due to endemic infection using 
repeated bulk milk sampling over a single lactation. 
Reductions in milk-related performance, and minor 
effects on herd fertility and mortality were identified, 
adding to the growing evidence that subclinical BoHV-
1 can result in ongoing losses in dairy herds. These data 
can contribute to analyzing the cost-benefit of applying 
BoHV-1 control strategies.
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